BIOSYNC: Bioelectronics for the Delivery of Synthetic Therapeutic with Wireless Control
A team from Columbia University, focusing on the Living Pharmacy track, which will address obesity and diabetes by developing the Bioelectronics for the Delivery of Synthetic Therapeutic with Wireless Control (BIOSYNC) device. They will explore a complementary approach to produce drugs that regulate appetite, digestion, and blood sugar.